DIACCURATE
DIACCURATE
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.diaccurate.com
Total Employee:
11+
Status:
Active
Similar Organizations
AntiGrade
AntiGrade is a biotechnology company.
Hepatera
Hepatera is a biotechnology company.
Kyowa Hakko Europe
Kyowa Hakko Europe is a biotechnology company.
UVera
UVera is a biotechnology company.
Current Employees Featured
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-08 | Diaccurate Appoints Laurence Riot Lamotte as Chief Financial Officer |
Official Site Inspections
http://www.diaccurate.com
- Host name: diaccurate.com
- IP address: 141.95.222.70
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Diaccurate"
Innovative clinical-stage biotech company - Evextabio
Evexta Bio, formerly Diaccurate, is a biopharmaceutical company exploring the new frontiers of oncology in search of daring novel therapeutic approaches with the potential to save lives. …See details»
Homepage | Evextabio
Oct 25, 2024 Diaccurate Appoints Scott Filosi as CEO. Our Oral Optimized S6 Kinase Inhibitor Is Now Rupitasertib. Our Selective KIF20A Inhibitor is now EVX-020 . Latest news. Evexta Bio Appoints Edith A. Perez as Scientific Advisor. …See details»
DIACCURATE Overview | SignalHire Company Profile
DIACCURATE is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology area. ... Organization Website: diaccurate.com : …See details»
Diaccurate - Products, Competitors, Financials, Employees, …
Diaccurate is a biotechnology company specializing in the development of ontology therapies. Use the CB Insights Platform to explore Diaccurate's full profile. Diaccurate - Products, …See details»
Diaccurate Announces the Appointment of Scott Filosi as CEO and ...
Paris, France, November 6, 2023 - Diaccurate SA, a clinical-stage biotechnology company focused on developing targeted therapeutics in oncology, - announces the appointment of …See details»
DIACCURATE Company Profile | PARIS, ILE DE FRANCE, France
Find company research, competitor information, contact details & financial data for DIACCURATE of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet.See details»
Diaccurate - VentureRadar
Today DIACCURATE is conducting proprietary development programs in disease indications with partial or total CD4 immunodeficiency. A phase I/II multi-center trial is already planned in HIV …See details»
evextabio.com
Want your own domain name? Learn more about the domain name extensions we manage Find a domain name similar to evextabio.comSee details»
DIACCURATE - Biotech.info
DIACCURATE was founded by Prof. Jacques THÈZE, an international leading authority in the fields of CD4 biology and HIV infection and its former student, Dr. Philippe POULETTY, who …See details»
Diaccurate - Funding, Financials, Valuation & Investors - Crunchbase
Jan 5, 2022 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 5, 2022: …See details»
Diaccurate - Contacts, Employees, Board Members, Advisors
Organization. Diaccurate . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. Diaccurate has 3 …See details»
DIACCURATE Company Profile - Office Locations, Competitors
DIACCURATE is a company specializing in the immunotherapy. It develops an enzymatic mechanism involved in the control of immune responses against HIV and other pathogens. …See details»
What is Diaccurate ? Company Culture, Mission, Values
See what employees say it's like to work at Diaccurate . Salaries, reviews, and more - all posted by employees working at Diaccurate .See details»
DIACCURATE Introduces Its World-leading Scientific Advisory Board
Jul 8, 2021 Dr. Dominique BRIDON, CEO of DIACCURATE, commented: "We feel honored to have gathered this world-renowned group of experts in our newly formed Scientific Advisory …See details»
A new generation of targeted therapies for advanced diseases
Jan 10, 2022 Discovering new and effective targeted therapies for serious and incurable diseases within the fields of oncology and immunology is at the forefront of Diaccurate’s work. …See details»
Diaccurate S.A.. (9/8/21). "Press Release: Diaccurate Acquires …
“Diaccurate is laying the foundations of a successful modern biotech company with a new highly specialized portfolio approach. This is an exciting agreement that will take the Company to the …See details»
Diaccurate - Tech Stack, Apps, Patents & Trademarks - Crunchbase
The intellectual property of Diaccurate includes 23 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, Diaccurate has …See details»
DIACCURATE ACQUIRES BIOKINESIS TO CREATE A SOLE-IN-CLASS …
O DIACCURATE is now developing 3 programs in cancer and immunotherapy o DIACCURATE will be initiating a first clinical trial by early 2022 . Paris, France, January 12, 2021 . By …See details»
Diaccurate introduces its world-leading scientific advisory board
Dec 21, 2020 Diaccurate announced the formation of its Scientific Advisory Board (SAB). Composed of 6 independent world-leading experts in the fields of basic and translational …See details»
The Guide to Employee Timekeeping: Streamline Your Workforce …
5 days ago Whether your organization is a small business or a large enterprise, our timekeeping solutions are designed to grow as your business does, ensuring long-term value. Our support …See details»